TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.